Please login to the form below
gilteritinib
This page shows the latest gilteritinib news and features for those working in and with pharma, biotech and healthcare.
FDA fast-tracks Astellas' Rydapt rival
FDA fast-tracks Astellas' Rydapt rival. AML treatment gilteritinib is currently involved in four phase III trials. ... Astellas Pharma has claimed a fast-track designation in the US for its FLT3 inhibitor gilteritinib, a drug that could rival
Latest news
-
Astellas extends phase III programme for Rydapt rival gilteritinib
Astellas extends phase III programme for Rydapt rival gilteritinib. Japanese group hopes its AML drug will soon compete with Novartis' recently-approved treatment. ... Given this reality, it is exciting to study gilteritinib in patients following a stem
-
Novartis' Rydapt approval ends long AML therapy drought
Meanwhile Astellas' gilteritinib - billed as a second-generation FLT3 inhibitor that avoids a resistance mechanism seen with earlier drugs - is also in late-stage testing.
More from news
Approximately 2 fully matching, plus 1 partially matching documents found.
Featured jobs
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 benefits
-
Scientific Team Lead
-
Competitive Salary
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
- Lead Medical Copywriter, Healthcare Brand Communications, London
-
Excellent package
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
-
Account Director
-
Negotiable
- Account Director – Global Healthcare PR
-
Salary TBC
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
- Experienced Editor, London, Medical Communications
-
Competitive package
-
Associate Medical Director
-
Salary TBC
-
Account Director - Digital
-
Great salary and benefits
-
Senior Account Manager - Med Comms
-
Highly Competitive Salary &Benefits
-
Associate Medical Director
-
Highly Competitive
-
Scientific Director
-
Highly Competitive Salary &Benefits
- Account Manager, Healthcare Advertising
-
Salary TBC
- Director Healthcare PR Communications
-
Salary TBC
- Senior Account Manager / Account Director - Med Comms
-
Great salary and benefits
Subscribe to our email news alerts
- Shire’s angioedema drug Takhzyro recommended in Europe
- Cuttsy+Cuttsy launch their latest patient e-book
- McCann Health London launch Urban Eye Test
- Encouraging data for GenSight’s blinding retinal disease gene therapy
- Keytruda hits survival targets in first-line kidney cancer
- UK ‘unicorn’ Oxford Nanopore bags $65m backing from Amgen
PMHub
3 Monkeys Zeno
3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...
Latest intelligence
- Retaining reader value in plain language summaries of clinical studies
- Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
- Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
- Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
- Making Europe a leader in bioscience: boosting trust and opening minds
- A vision of Paris as Europe’s leading hub for life sciences innovation...
Quick links
Infographics
